Following the trend of the broader pharmaceutical world, Johnson & Johnson’s medtech division is interested and ready for partnering out – pushing a decentralized business model that focuses heavily on external collaboration.
“We have the humility to understand that we don’t own all the information or knowledge on medical technology,” Martin Fitchet, global head of R&D for J&J Medical Devices, said in an interview at this week’s AdvaMed 2015 conference in San Diego. “There’s a big world out there. Academia. Startups. Other companies. Government. All working on technologies that we’d love to partner with, and add our expertise.”
Help employers find you! Check out all the jobs and post your resume.
